Skin tests with soluble tumor membrane antigens in patients with transitional cell cancers.
Patients with transitional cell cancers and control patients with other forms of cancer were tested with cell membranes and soluble membrane antigens with the use of delayed hypersensitivity skin tests. These ongoing and parallel studies in which LMI tests are used have not been completed.
D000951:Antigens, Neoplasm / Q000008:administration & dosage*; D000954:Antigens, Surface / Q000008:administration & dosage*; D002295:Carcinoma, Transitional Cell / Q000276:immunology*; D002464:Cell Migration Inhibition; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D012882:Skin Tests; D001749:Urinary Bladder Neoplasms / Q000276:immunology*
D000951:Antigens, Neoplasm; D000954:Antigens, Surface